Browse Category

Stock Market News 23 December 2025

Johnson & Johnson Stock (JNJ) Slips After Record $1.5B Talc Verdict: News, Forecasts, and What to Watch Into 2026

Johnson & Johnson Stock (JNJ) Slips After Record $1.5B Talc Verdict: News, Forecasts, and What to Watch Into 2026

Johnson & Johnson Stock (JNJ) Slips After Record $1.5B Talc Verdict: News, Forecasts, and What to Watch Into 2026 Johnson & Johnson (NYSE: JNJ) ended Tuesday, December 23, 2025, in the spotlight for reasons that cut both ways for investors: a headline-grabbing talc-related jury verdict that revived long-running legal risk concerns—and a steady drumbeat of regulatory and product updates that reinforce the company’s growth narrative across Innovative Medicine and MedTech. In late trading on Dec. 23, JNJ traded around $205.43, down about 0.9% on the day, after touching an intraday range roughly between $203.41 and $207.23. Below is a comprehensive
Rigetti Computing (RGTI) Stock News Today: Analysts’ 2026 Targets, Quantum Roadmap Milestones, and Why Shares Are Swinging

Rigetti Computing (RGTI) Stock News Today: Analysts’ 2026 Targets, Quantum Roadmap Milestones, and Why Shares Are Swinging

December 23, 2025 — Rigetti Computing, Inc. (NASDAQ: RGTI) is back in the spotlight as quantum-computing stocks churn through sharp end‑of‑year moves. By 17:55 UTC (about 12:55 p.m. ET), Rigetti shares traded around $25.24, down roughly 6% on the session after a stronger prior close, with an intraday range near $25.20–$26.82 and volume above 20 million shares. The day’s pullback underscores a defining feature of the “pure‑play” quantum group: even modest headlines, analyst notes, or positioning flows can translate into outsized price swings. And with multiple Wall Street firms now publishing fresh coverage and price targets into 2026, Rigetti’s debate
StoneCo (STNE) Stock Jumps on New R$2 Billion Buyback: Today’s News, Analyst Targets, and 2026 Outlook (Dec. 23, 2025)

StoneCo (STNE) Stock Jumps on New R$2 Billion Buyback: Today’s News, Analyst Targets, and 2026 Outlook (Dec. 23, 2025)

Dec. 23, 2025 — StoneCo Ltd. (NASDAQ: STNE) is back in the spotlight after a shareholder-return update lit a match under the stock. Shares were trading around $14.86, up roughly 5% in Tuesday’s session, as investors reacted to a new repurchase authorization and fresh detail on how the company has been returning capital. Benzinga The headline: StoneCo disclosed plans tied to R$3 billion in “excess capital” from 2024 and launched a new share repurchase program of up to R$2 billion, a move that signals confidence and keeps buybacks at the center of the company’s capital-allocation story. Investing.com Below is what
23 December 2025
Uber Stock (NYSE: UBER) on Dec. 23, 2025: Robotaxi Momentum Meets FTC Lawsuit Risk as Wall Street Reprices the Story

Uber Stock (NYSE: UBER) on Dec. 23, 2025: Robotaxi Momentum Meets FTC Lawsuit Risk as Wall Street Reprices the Story

Uber Technologies, Inc. (NYSE: UBER) is back at the center of the autonomous-vehicle debate heading into year-end trading, with investors weighing a fresh robotaxi catalyst in the U.K. against intensifying regulatory scrutiny in the U.S. As of Tuesday, December 23, 2025, Uber shares were trading around $80.52, down about 0.9% on the day after an intraday high near $81.67. With the stock hovering in the low $80s, Uber’s equity value remains in the “mega-cap-adjacent” tier, with market-cap estimates clustering around ~$170 billion depending on the data source and timestamp. Nasdaq+1 What’s driving the tape isn’t a single metric—it’s a narrative
Procter & Gamble Stock (NYSE: PG) Today: What’s Driving Shares on Dec. 23, 2025 — Analyst Targets, Earnings Outlook, and Key Risks

Procter & Gamble Stock (NYSE: PG) Today: What’s Driving Shares on Dec. 23, 2025 — Analyst Targets, Earnings Outlook, and Key Risks

Procter & Gamble (The Procter & Gamble Company, ticker PG) is closing out 2025 with its stock hovering near the lower half of its 52-week range—an area that’s attracting fresh attention from analysts and long-term dividend investors alike. As of December 23, 2025, PG shares are trading around $143.6, up modestly on the day after Monday’s pullback, with investors now looking ahead to two near-term catalysts: a CEO transition on January 1, 2026, and the company’s fiscal Q2 2025/26 earnings event on January 22, 2026. Barron’s+1 Below is a comprehensive roundup of the latest PG stock news, forecasts, and analysis
Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Inc. (NYSE: V) stock is back in the spotlight on Dec. 23, 2025, as fresh holiday spending data adds new color to the consumer-demand picture—and as investors weigh the payments giant’s fast-moving strategy in stablecoin settlement and AI-driven “agentic commerce.” As of early afternoon Tuesday, Visa shares were modestly higher, trading around $354 (roughly +0.5% on the day), with the company’s investor relations quote page listing a 52-week range of about $299 to $375. Visa Investor Relations Below is what’s driving headlines around Visa stock today, plus the forecasts and key debates shaping the outlook into 2026. Visa stock
23 December 2025
ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

December 23, 2025 — Shares of ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) jumped Tuesday after the company disclosed that its board has received multiple competing proposals to acquire the company’s outstanding shares, escalating a strategic review that has been underway for months. ZIM Investors+2Benzinga+2 As of 17:15 UTC on Tuesday, Dec. 23, ZIM traded at $20.96, after touching an intraday high of $22.35 and low of $20.72 on unusually heavy volume. What’s driving the move is simple in headline form—“buyout proposals”—but the investor calculus is more complicated: ZIM sits at the intersection of (1) a potentially high-stakes corporate event
23 December 2025
NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

Dec. 23, 2025 — NexGen Energy Ltd. (TSX: NXE | NYSE: NXE | ASX: NXG) is back in the spotlight as investors weigh a familiar uranium-developer question with very unfamiliar stakes: how close is “close” to a construction decision? TMX Newsfile+1 For NexGen, that question largely funnels into one major catalyst: the Canadian Nuclear Safety Commission (CNSC) process for its 100%-owned Rook I Project in Saskatchewan’s uranium-rich Athabasca Basin. Part 1 of the CNSC hearing took place on Nov. 19, 2025, and Part 2 is scheduled for Feb. 9–13, 2026, after which the Commission will make its approval determination. Canadian
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics Inc. (NASDAQ: GPCR) is ending 2025 in the middle of one of biotech’s hottest battlegrounds: oral weight-loss medicines. As of Dec. 23, 2025, GPCR shares were trading around $67.50 in U.S. session data, after a volatile stretch driven by blockbuster obesity-trial headlines, a major equity financing, and a wave of analyst price-target updates. Below is a comprehensive roundup of the latest news, forecasts, and analysis available as of 23.12.2025, and what investors are watching next. What is Structure Therapeutics, and why does GPCR trade like a headline detector? Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule
Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck & Co., Inc. (NYSE: MRK) is closing in on year-end with a rare mix of policy-driven headlines, regulatory acceleration, and pipeline catalysts that are shaping investor expectations for 2026 and beyond. From a White House-backed drug-pricing framework that offers tariff relief to drugmakers, to the FDA’s fast-track voucher program attaching itself to two Merck assets with blockbuster potential, MRK stock is being evaluated not just on quarterly numbers—but on whether Merck can extend growth beyond Keytruda while navigating intensifying U.S. drug-pricing scrutiny. Reuters+2Reuters+2 Below is a comprehensive, publication-ready roundup of today’s MRK stock action, the key news moving the
Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Corporation (NYSE: BAC) stock is trading near its recent highs as 2025 winds down, with investors balancing three big forces: a shifting interest-rate outlook, improving Wall Street deal momentum, and a growing stack of analyst upgrades heading into the bank’s next earnings report. As of Tuesday, December 23, 2025, BAC was trading around $55.96, modestly higher on the session, after touching an intraday high near $56.17. Investing.com Below is a full round-up of the latest news, forecasts, and market analysis available as of 23.12.2025, plus the key catalysts that could decide whether Bank of America stock breaks
Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp (NASDAQ: HUT; TSX: HUT) is back in the market’s spotlight on December 23, 2025, as investors continue to re-rate the company less like a pure-play Bitcoin miner and more like a power-and-data-center platform for the AI era. The stock’s action has been anything but sleepy. After opening sharply lower, shares reversed higher and pushed into the low-to-mid $50s intraday. As of 17:04 UTC on Dec. 23, Hut 8 traded at $53.62, up 6.41% on the day, with an intraday range of $48.02 to $53.86 on roughly 6.7 million shares. So what’s driving the whiplash—and why are analysts
Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Corporation (NASDAQ: INTC) is ending 2025 in a familiar place for long-time investors—right at the center of a high-stakes debate about what Intel is supposed to be. Is it a classic CPU giant fighting to regain product leadership? A U.S.-anchored foundry champion meant to rival TSMC? Or both at once? On Tuesday, Dec. 23, 2025, that identity question is colliding with a fresh wave of Wall Street calls, a closely watched Nvidia investment now cleared by U.S. antitrust agencies, and renewed arguments that Intel’s foundry ambitions may be limited by one simple issue: trust. Reuters+2Fudzilla+2 Intel stock price today:
Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

December 23, 2025 — Lionsgate Studios Corp stock is having a loud day in the market. Shares of Lionsgate Studios Corp (NYSE: LION) traded around $9.06 Tuesday, up roughly 8%–9%, after touching an intraday high near $9.23 (and a low around $8.54). That price action matters because LION has been flirting with (and now pushing beyond) its prior 52-week high around $9.14—a technical milestone that tends to attract momentum traders and forces skeptics to revisit the “this is just a sleepy studio stock” thesis. Lionsgate Investors+1 Below is what’s new as of Dec. 23, 2025, plus the most relevant forecasts
23 December 2025
Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

December 23, 2025 — Eli Lilly and Company stock (NYSE: LLY) is holding near record territory as investors digest a fresh twist in the weight-loss drug race: the FDA has cleared Novo Nordisk’s first oral version of Wegovy, intensifying competition right as Lilly pushes its own once-daily pill candidate, orforglipron, toward a potential 2026 approval. As of 15:11 UTC on Tuesday, LLY traded around $1,077, slightly above the prior close, after moving between roughly $1,057 and $1,088 during the session. The backdrop is simple but powerful: the obesity market is expanding fast, and the “next chapter” is about convenience, supply,
Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Dec. 23, 2025 — Citigroup, Inc. stock is closing out 2025 with a tailwind that investors have been waiting years to see: meaningful signs that long-running regulatory overhangs are starting to lift. Coming into Tuesday’s session, Citi (NYSE: C) was already riding fresh momentum after a strong Monday rally pushed the shares to a new 52‑week high. MarketWatch The year-end story around Citigroup stock is no longer just about a bank “in turnaround.” It’s increasingly about whether CEO Jane Fraser’s multi-year transformation is finally translating into a cleaner regulatory slate, a simpler operating model, and a clearer path to higher
23 December 2025
Costco Stock (COST) Outlook on Dec. 23, 2025: Earnings Beat, Holiday Spending Signals, and Wall Street Forecasts for 2026

Costco Stock (COST) Outlook on Dec. 23, 2025: Earnings Beat, Holiday Spending Signals, and Wall Street Forecasts for 2026

Costco Wholesale Corporation (NASDAQ: COST) is heading into the final stretch of 2025 in a familiar position operationally—strong sales, loyal members, and steady expansion—yet in a less familiar spot in the market: trading close to its 52‑week low after a year of choppy performance. As of Tuesday, Dec. 23, 2025, Costco shares were trading around $853 in late U.S. trading, up modestly on the day. StockAnalysis But the bigger story is the reset behind the scenes: even after Costco delivered a first‑quarter fiscal 2026 earnings beat and posted mid‑single‑digit comparable sales growth, the stock has faced questions about valuation, membership
Polestar Automotive Holding UK PLC Stock (PSNY) Jumps as $300 Million BBVA–Natixis Funding Closes: Latest News, Forecasts and What’s Next

Polestar Automotive Holding UK PLC Stock (PSNY) Jumps as $300 Million BBVA–Natixis Funding Closes: Latest News, Forecasts and What’s Next

Polestar Automotive Holding UK PLC stock is back in traders’ headlights on Tuesday, December 23, 2025, after the company confirmed it closed a roughly $300 million funding transaction tied to European investment banks BBVA and Natixis—a rare “fresh cash in the door” moment for an EV maker that has spent much of 2025 battling liquidity anxiety. MarketScreener In U.S. trading on Dec. 23, PSNY changed hands around $15.37 with an intraday range of roughly $13.97–$15.60, extending a sharp multi-day move following last week’s financing announcements. That price action is the headline. The story underneath it is more complicated—and more interesting:
Century Aluminum (CENX) Stock Climbs After Wells Fargo Raises Price Target to $46: News, Forecasts, and What to Watch on Dec. 23, 2025

Century Aluminum (CENX) Stock Climbs After Wells Fargo Raises Price Target to $46: News, Forecasts, and What to Watch on Dec. 23, 2025

Century Aluminum Company stock (NASDAQ: CENX) pushed higher on Tuesday, Dec. 23, after Wells Fargo boosted its 12‑month price target—adding fresh fuel to a rally that has increasingly been tied to one big theme: tight metal supply meeting tariff-driven price dislocations. Benzinga+2TipRanks+2 Below is the latest on today’s catalyst, the macro forces behind the move, what analysts are forecasting now, and the key company-specific drivers investors are watching into 2026. What’s driving Century Aluminum stock today The immediate spark is a Wells Fargo price-target increase to $46 from $37, while maintaining an Overweight rating. The firm’s thesis centers on supply
23 December 2025
Robinhood (HOOD) Stock News Today, Dec. 23, 2025: Prediction Markets Expansion, Analyst Forecasts, and the 2026 Outlook

Robinhood (HOOD) Stock News Today, Dec. 23, 2025: Prediction Markets Expansion, Analyst Forecasts, and the 2026 Outlook

Robinhood Markets, Inc. (NASDAQ: HOOD) is ending 2025 in the spotlight again—this time at the intersection of retail trading momentum, crypto-linked volatility, and a fast-growing push into prediction markets that looks increasingly like a new revenue engine. On Tuesday, December 23, 2025, HOOD shares traded lower, hovering around $119 and down roughly 2%–3% intraday after Monday’s close near $122. StockAnalysis The decline comes as crypto-related equities broadly softened alongside a pullback in Bitcoin. Barron’s Still, the bigger story is what investors are debating heading into 2026: whether Robinhood’s product expansion (especially event contracts), international growth plans, and scale economics can

Stock Market Today

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
ASML stock price snaps back as AI spending bets return, with ex-dividend date next

ASML stock price snaps back as AI spending bets return, with ex-dividend date next

7 February 2026
ASML shares rose 3.84% Friday in Amsterdam to 1,193.80 euros, rebounding with global chip stocks after Amazon signaled a sharp increase in AI-related capital spending. The stock goes ex-dividend Feb. 9 ahead of a 1.60-euro interim payout. ASML’s Nasdaq shares climbed 4.64% to $1,413.01. Despite Friday’s gains, the Amsterdam listing finished the week about 2.5% lower.
Go toTop